News

Response from Oxford Nanopore Inc. to new lawsuit from PacBio

In Brief: Oxford Nanopore updates at the Nanopore Community meeting in New York

• Event highlight

2017 was busy, and here's why. Happy New Year 2018

A summer* of nanopore – are you up to date?

Oxford Nanopore to showcase what you’re missing matters when investigating disease enabled by nanopore sequencing at the American Society of Human Genetics

Oxford Nanopore launches TurBOT beta access to deliver optimised sample-to-result product, strengthening collaboration with Tecan

Oxford Nanopore announces global distribution agreement with Avantor® for handheld MinION DNA/RNA sequencer

• MinION

Nature paper shows power of genomic surveillance of Zika

Nanopore Community Meeting - Day 2 writeup

• Event highlight

London Calling: Day 1 (morning) writeups

• Event highlight

Interview: Sequencing the poplar with PromethION

• Interview
• PromethION
• Plant

Amgen invests £50 million ($66 million) in Oxford Nanopore Technologies

American Association of Cancer Research: Oxford Nanopore showcases breakthrough technology to generate most comprehensive insights into cancer genomes

• Cancer research

22 highlights to remember from 2022

18 highlights from 2018 (and a New Year quiz)

American Association of Cancer Research: Oxford Nanopore showcases transformative technology for accelerating oncology research

Oxford Nanopore technology used to uncover insights into complex immune system genes, paving the way for future antibody therapies

Oxford Nanopore Technologies collaborates with Twist Bioscience to launch Pharmacogenomics Beta Programme and advance personalised medicine

• Long-read
• Biopharma
• Clinical research

Oxford Nanopore Technologies and BugSeq announce collaboration to provide fully automated analysis solutions for rapid pathogen identification and ant

• Microbiology
• Infectious disease

Oxford Nanopore’s ORG.one hits milestone, announces new focus on endangered species

• Whole genome
• Long-read